Top Markets
Coin of the day
Circio Holding ASA Circio Holding ASA

Circio Holding ASA

CRNA
Rang in Aktien #18604
Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in... Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in 2010, specializes in the development of advanced circular RNA and immunotherapy treatments. Among its key innovations is TG01, a cancer vaccine aimed at specific driver mutations, which is currently progressing through three clinical trials for indications including multiple myeloma, pancreatic cancer, and lung cancer. The company also pioneers the circVec circRNA vector platform, an adaptable genetic module designed to facilitate the creation of diverse functional circular RNAs within human cells. This circVec platform is further supported by a collaborative agreement with Certest Biotec, S.L., focusing on its formulation. Formerly known as Targovax ASA, the company officially rebranded to Circio Holding ASA in May 2023.
Aktienkurs
$0.88044964
Zuletzt synchronisiert: 2026-07-31
Marktkapitalisierung
$192.54M
Veränderung (1 Tag)
-0.71%
Veränderung (1 Jahr)
1,362.12%
Land
NO
Handel Circio Holding ASA (CRNA)

Kategorie

Kursverlauf für Circio Holding ASA (CRNA)
Höchster Schlusskurs: $0.84 am 2026-07-01

Niedrigster Schlusskurs: $0.90 am 2016-07-01
Kursverlauf der Aktie von Circio Holding ASA von 2016 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 262.04%
2025 82.17%
2024 -90.40%
2023 491.05%
2022 -50.55%
2021 -78.41%
2020 50.32%
2019 -17.19%
2018 -55.49%
2017 45.27%
2016 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$549.38 41.89%
US
$1.05K 47.72%
NL
$148.35 499.86%
US
$121.62 -12.98%
AU
$764.47 6.25%
CH